Healthcare utilization and comorbidity in chronic lymphocytic leukemia
Clinical Epidemiology Jan 06, 2022
Rotbain EC, Rostgaard K, Andersen MA, et al. - Chronic lymphocytic leukemia (CLL) diagnosis could reveal incipient diseases and worsen comorbidities and thereby have considerably broader health implications compared to those directly associated with CLL.
Data from Danish nation-wide registers were used to analyze current patterns of healthcare utilization in CLL.
Participants were 9,170 CLL patients with a median age of 71 years, of whom 35% had ≥ 1 comorbidity.
A marked increase in healthcare utilization was observed upon CLL diagnosis both in patients with and without comorbidities.
During the year after CLL diagnosis, hospitalization occurred in 39%, emergency room visit in 16%, out-patient clinic visit in 88%, and receipt of prescription drugs in 93%.
Increased healthcare utilization of all types, except for contacts to hematological departments, was evident in relation to both individual comorbidities and the total number of comorbidities.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries